Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

How does one demonstrate cytoprotection in man?

M M Cohen1

  • 1Department of Surgery, University of Toronto, Ontario, Canada.

Scandinavian Journal of Gastroenterology. Supplement
|January 1, 1989
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Confirmation of an oroacral pattern of anomalies: a disruption?

American journal of medical genetics·1992
Same author

Bannayan-Riley-Ruvalcaba syndrome.

American journal of medical genetics·1992
Same author

Perspectives on holoprosencephaly: Part II. Central nervous system, craniofacial anatomy, syndrome commentary, diagnostic approach, and experimental studies.

Journal of craniofacial genetics and developmental biology·1992
Same author

Laparoscopic cholecystectomy: the anaesthetist's point of view.

Canadian journal of anaesthesia = Journal canadien d'anesthesie·1992
Same author

Discovery and expository methods in teaching visual consonant and word identification.

Journal of speech and hearing research·1992
Same author

Beare-Stevenson cutis gyrata syndrome.

American journal of medical genetics·1992

Cytoprotection research in humans needs more clinical trials. Future studies should compare prostaglandins with H2 blockers to prove cytoprotective effects in various gastric conditions.

Area of Science:

  • Gastroenterology
  • Pharmacology

Background:

  • Cytoprotection is a key concept in gastrointestinal research.
  • Human experimental models for cytoprotection have limitations.
  • Prostaglandins are investigated for their potential gastroprotective effects.

Purpose of the Study:

  • To evaluate the efficacy of cytoprotection in human subjects.
  • To explore the utility and constraints of human models for cytoprotection studies.
  • To review recent prostaglandin trials for preventing gastric damage.

Main Methods:

  • Discussion of the term 'cytoprotection'.
  • Analysis of human experimental models for cytoprotection.
  • Reporting on recent clinical trials of prostaglandins in arthritic patients.

Related Experiment Videos

Main Results:

  • Human models for cytoprotection have inherent limitations.
  • Recent trials show prostaglandins' potential in preventing gastric damage in specific patient groups.
  • Further research is required to establish definitive cytoprotective benefits.

Conclusions:

  • Additional clinical trials are essential for demonstrating cytoprotection.
  • Studies should encompass peptic ulcer disease, drug-induced gastropathy, and stress ulcers.
  • Direct comparisons with H2 blockers or specific prostaglandin dosing are needed for conclusive evidence.